×

Immunotherapy against melanoma and other cancers

  • US 10,385,110 B2
  • Filed: 10/19/2018
  • Issued: 08/20/2019
  • Est. Priority Date: 04/21/2016
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating a patient who has cancer comprising administering to the patient a population of activated T cells that selectively recognize cancer cells that present a peptide consisting of the amino acid sequence of ILLDRLFSV (SEQ ID NO:

  • 91),wherein said cancer is selected from the group consisting of head-and-neck cancer, melanoma, acute myelogenous leukemia, breast cancer, bile duct cancer, brain cancer, chronic lymphocytic leukemia, colorectal carcinoma, esophageal cancer, gallbladder cancer, gastric cancer, hepatocellular cancer, non-Hodgkin lymphoma, non-small cell lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, renal cell cancer, small cell lung cancer, urinary bladder cancer, and uterine cancer.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×